Cochlear manufactures implantable hearing solutions, including cochlear implants and bone conduction devices, used by more than 700,000 recipients in over 180 countries.
Cochlear is the world's leading implantable hearing solutions company. Its cochlear implants and bone conduction devices restore the ability to experience sound for people with hearing loss, and more than 700,000 recipients across over 180 countries use its products. The company employs more than 4,000 people in more than 30 countries.
The business designs and manufactures regulated medical devices, supported by a research and development programme that attracts over AUD$180 million in investment each year and a portfolio of more than 100 patent families. Its technical work spans implantable hearing devices, cochlear implants, bone conduction technology and hearing technology R&D. Cochlear states that its devices are chosen more often than those of any other hearing implant company.
Operations are global, with recipients in more than 180 countries and staff in over 30. The company traces its origins to the work of Professor Graeme Clark. It describes its purpose as helping people hear and be heard, connecting people to conversations, music and other moments that matter.
